Skip to main content
Livermore
Livermore
ZHEN

Private Management Group Inc

SEC CIK
0001142031
Latest filing
Jul 31, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Private Management Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
513,319
Value
$17.4M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Private Management Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026513,319$17.4M0.5%−197,079−27.7%ReducedHolders
Q1 2026710,398$21.4M0.6%−178,797−20.1%ReducedHolders
Q4 2025889,195$27.8M0.8%−303,794−25.5%ReducedHolders
Q3 20251,192,989$24.1M0.7%−162,630−12.0%ReducedHolders
Q2 20251,355,619$22.7M0.7%−5,804−0.4%ReducedHolders
Q1 20251,361,423$20.9M0.7%+179,758+15.2%AddedHolders
Q4 20241,181,665$26.0M0.9%−92,332−7.2%ReducedHolders
Q3 20241,273,997$23.0M0.8%−101,434−7.4%ReducedHolders
Q2 20241,375,431$22.4M0.9%−92,921−6.3%ReducedHolders
Q1 20241,468,352$20.7M0.8%−49,086−3.2%ReducedHolders
Q4 20231,517,438$15.8M0.6%−98,730−6.1%ReducedHolders
Q3 20231,616,168$16.5M0.7%−47,641−2.9%ReducedHolders
Q2 20231,663,809$12.5M0.5%+378,600+29.5%AddedHolders
Q1 20231,285,209$11.4M0.5%−9,547−0.7%ReducedHolders
Q4 20221,294,756$11.8M0.5%−821,603−38.8%ReducedHolders
Q3 20222,116,359$17.1M0.8%−98,442−4.4%ReducedHolders
Q2 20222,214,801$16.7M0.7%+9,272+0.4%AddedHolders
Q1 20222,205,529$20.7M0.8%+105,115+5.0%AddedHolders
Q4 20212,100,414$16.8M0.7%−89,990−4.1%ReducedHolders
Q3 20212,190,404$21.3M0.9%+80,842+3.8%AddedHolders
Q2 20212,109,562$20.9M0.9%+177,052+9.2%AddedHolders
Q1 20211,932,510$22.3M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.